Загрузка...
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
SIMPLE SUMMARY: In this review, we examined relevant clinical trial results with immune checkpoint inhibitors in patients with metastatic urothelial cancer. We also focused on the potential of immunotherapy in the adjuvant and neoadjuvant setting or as part of drug combinations. Finally, we briefly...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7795541/ https://ncbi.nlm.nih.gov/pubmed/33401585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010131 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|